Researchers at The University of Texas MD Anderson Cancer Center have found that a mitochondrial enzyme, GFER, creates an ...
Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer
Curasight A/S ("Curasight" or "the Company" ? TICKER: CURAS) today announced the successful and safe dosing of the first patient in the Phase 1 trial using uTREAT in brain cancer (high grade gliomas).
The Federal Government on Thursday inaugurated the Environmentally Sound Management and Disposal of PCBs Treatment Centre in ...
Avacta reported new pharmacology data on its second oncology asset, FAP-Exd (AVA6103), on Thursday, showing sustained tumor ...
The president promoted his economic accomplishments in a defiant address. But some voters are feeling the pinch of stubborn ...
Athira has acquired an exclusive global license (excluding Asia and certain countries in the Middle East) from Sermonix Pharmaceuticals, Inc. for rights to develop and commercialize lasofoxifene, a ...
Here are the 10 most-read news stories about HMS-led discoveries in 2025.
The Viksit Bharat Guarantee for Rozgar and Ajeevika Mission (Gramin) Bill, 2025, which seeks to repeal the Mahatma Gandhi ...
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. PFE’s New Liver Cancer Trial: Early Signal to Watch The study, officially ...
Miguel-Angel Perales, MD, spoke with Targeted Oncology® about the problems the CAR T Vision group has identified and the key ...
INDIA bloc MPs, including TMC, hold a march from the Gandhi statue to Makkar Dwar in protest against the VB-G RAM G ...
Each year, CBS News Chicago remembers some of the many people who made the city tick through a variety of talents and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results